234 related articles for article (PubMed ID: 17977261)
1. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose.
Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B
J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261
[TBL] [Abstract][Full Text] [Related]
2. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
[TBL] [Abstract][Full Text] [Related]
3. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
[TBL] [Abstract][Full Text] [Related]
4. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
6. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.
Kano H; Kondziolka D; Khan A; Flickinger JC; Lunsford LD
J Neurosurg; 2009 Oct; 111(4):863-73. PubMed ID: 19284227
[TBL] [Abstract][Full Text] [Related]
7. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
8. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
[TBL] [Abstract][Full Text] [Related]
9. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes.
Bennion NR; Nowak RK; Lyden ER; Thompson RB; Li S; Lin C
Pract Radiat Oncol; 2016; 6(5):e155-e162. PubMed ID: 26961715
[TBL] [Abstract][Full Text] [Related]
11. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
12. Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion.
Kim YH; Kim DG; Han JH; Chung HT; Kim IK; Song SW; Park JH; Kim JW; Kim YH; Park CK; Kim CY; Paek SH; Jung HW
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):61-7. PubMed ID: 22580122
[TBL] [Abstract][Full Text] [Related]
13. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma.
Paek SH; Chung HT; Jeong SS; Park CK; Kim CY; Kim JE; Kim DG; Jung HW
Cancer; 2005 Aug; 104(3):580-90. PubMed ID: 15952200
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing.
Hasegawa T; Kida Y; Kato T; Iizuka H; Yamamoto T
J Neurosurg; 2011 Dec; 115(6):1078-86. PubMed ID: 21961962
[TBL] [Abstract][Full Text] [Related]
15. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing.
Han JH; Kim DG; Chung HT; Paek SH; Jung HW
Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404
[TBL] [Abstract][Full Text] [Related]
16. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
[TBL] [Abstract][Full Text] [Related]
17. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL
Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864
[TBL] [Abstract][Full Text] [Related]
19. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
[TBL] [Abstract][Full Text] [Related]
20. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
